| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/21/2008 | US20080044820 La1 - the genome of a lactobacillus strain |
| 02/21/2008 | US20080044810 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 02/21/2008 | US20080044808 West nile virus antigen and assay |
| 02/21/2008 | US20080044806 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads |
| 02/21/2008 | US20080044484 Use of polymeric nanoparticles for vaccine delivery |
| 02/21/2008 | US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases |
| 02/21/2008 | US20080044436 Method for Screening and Compositions for Treating Cancers |
| 02/21/2008 | US20080044435 Tat-Based Tolerogen Compositions and Methods of Making and Using Same |
| 02/21/2008 | US20080044433 Epitopes of hepatitis C virus |
| 02/21/2008 | US20080044432 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080044427 Plant virus |
| 02/21/2008 | US20080044426 Novel Atypical Pneumonia-Causing Virus |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044422 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 02/21/2008 | US20080044418 Tumor Antigens and Uses Thereof |
| 02/21/2008 | US20080044416 Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| 02/21/2008 | US20080044415 Hepatocyte growth factor receptor antagonists and uses thereof |
| 02/21/2008 | US20080044411 Human glp-1 mimetibodies, compositions, methods and uses |
| 02/21/2008 | US20080044409 Inflammatory mediator antagonists |
| 02/21/2008 | US20080044407 Mage-a3/hpv 16 peptide vaccines for head and neck cancer |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | US20080044377 Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine |
| 02/21/2008 | US20080044376 Cytokine Design |
| 02/21/2008 | US20080044356 Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof |
| 02/21/2008 | US20080044352 pH-sensing dye/lipoprotein conjugates; high-throughput assays; 2-{[1E,3E,5E)-5-(3-methyl-3-(5-carboxypentyl)-5-sulfo-1,3-dihydro-2H-indol-2-ylidene]-1,3-pentadienyl}-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium dye conjugate |
| 02/21/2008 | CA2697742A1 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 02/21/2008 | CA2661122A1 Method of screening for compounds with anti-amyloid properties |
| 02/21/2008 | CA2660835A1 Dpp-iv resistant gip hybrid polypeptides with selectable propperties |
| 02/21/2008 | CA2660743A1 Immunogenic pcpa polypeptides and uses thereof |
| 02/21/2008 | CA2660516A1 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | CA2660294A1 Diuretic and natriuretic polypeptides |
| 02/21/2008 | CA2660204A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/21/2008 | CA2660178A1 Promiscuous her-2/neu cd4 t cell epitopes |
| 02/21/2008 | CA2660171A1 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase |
| 02/21/2008 | CA2659655A1 Salicylanilides enhance oral delivery of therapeutic peptides |
| 02/21/2008 | CA2659585A1 Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein |
| 02/21/2008 | CA2659552A1 Immunogens from uropathogenic escherichia coli |
| 02/21/2008 | CA2659252A1 Plants with enhanced size and growth rate |
| 02/21/2008 | CA2658715A1 Recombinant interferon-beta with enhanced biological activity |
| 02/21/2008 | CA2658557A1 Optimized antibodies that target cd19 |
| 02/21/2008 | CA2654968A1 Identification of genes implicated in the virulence of streptococcus agalactiae |
| 02/20/2008 | EP1890152A1 Determination of renin/prorenin receptor activity |
| 02/20/2008 | EP1889916A1 A method for the production of the recombinant hoxb4 protein containing his tag at c-terminal and use thereof |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889913A1 Transcription factor islet-brain 1 (IB1) |
| 02/20/2008 | EP1889912A1 Transcriptions Factor Islet-Brain 1 (IB1) |
| 02/20/2008 | EP1889909A1 Improvement of disease resistance of plant by introducing transcription factor gene |
| 02/20/2008 | EP1889908A1 Anti-cd14 antibody-fused protein |
| 02/20/2008 | EP1889905A1 Method for amelioration of disease condition induced by mood disorder |
| 02/20/2008 | EP1889852A1 Method for the diagnosis and prognosis of demyelinating diseases and for the development of medicaments against demyelinating diseases |
| 02/20/2008 | EP1889823A1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation |
| 02/20/2008 | EP1888755A2 Means and methods to modulate flavonoid biosynthesis in plants and plant cells |
| 02/20/2008 | EP1888751A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/20/2008 | EP1888635A2 Neural regeneration peptides and methods for their use |
| 02/20/2008 | EP1888634A2 Mhc class i and ii peptide antigens derived from tumour antigen 5t4 |
| 02/20/2008 | EP1888633A2 Evolved interferon-alpha polypeptides |
| 02/20/2008 | EP1888632A2 Cytokine |
| 02/20/2008 | EP1888631A2 Therapeutic composition for use in the prevention and treatment of bone metastases |
| 02/20/2008 | EP1888630A2 A recombinant method for production of an erythropoiesis stimulating protein |
| 02/20/2008 | EP1888629A2 Neuritogenic peptides |
| 02/20/2008 | EP1888628A1 A peptide ligand to impair cancer cell migration |
| 02/20/2008 | EP1888627A2 Nucleic acids and polypeptides that are useful in controlling neuronal regeneration |
| 02/20/2008 | EP1888626A2 A therapeutic agent for ab related disorders |
| 02/20/2008 | EP1888625A2 Malaria vaccines |
| 02/20/2008 | EP1888624A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 02/20/2008 | EP1888623A1 Chimeric proteins for measuring atp concentrations in pericellular space and related screening method |
| 02/20/2008 | EP1888622A1 Compositions for inducing an immune response against hepatitis b |
| 02/20/2008 | EP1888621A2 Porcine circovirus type 2 vaccines |
| 02/20/2008 | EP1888620A1 Method for producing virus-type particles containing an active substance |
| 02/20/2008 | EP1888208A2 A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method |
| 02/20/2008 | EP1888119A2 Pegylated g-csf polypeptides and methods of producing same |
| 02/20/2008 | EP1888111A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 02/20/2008 | EP1888109A2 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/20/2008 | EP1888106A2 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 02/20/2008 | EP1888096A2 Milk fat globule epidermal growth factor-factor viii and sepsis |
| 02/20/2008 | EP1887859A1 Animal model for the human immune system, and method for producing the same |
| 02/20/2008 | EP1465989B1 Growth factor modified protein matrices for tissue engineering |
| 02/20/2008 | EP1458867B1 Gene promoters |
| 02/20/2008 | EP1419235A4 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/20/2008 | EP1385370B1 Animicrobial polypeptides and their uses |
| 02/20/2008 | EP1330474B1 Diagnostic use of a specific co-activator for human nuclear receptors |
| 02/20/2008 | EP1243651B1 Method of detecting sexual differentiation disruptor |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1177211B1 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 02/20/2008 | EP1163349B1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 02/20/2008 | EP1154791B1 Neisserial vaccine compositions and methods |
| 02/20/2008 | EP1121437B1 Metastatic breast and colon cancer regulated genes |
| 02/20/2008 | EP1100922B1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | EP1039873B1 Keratin-based hydrogel for biomedical applications and method of production |
| 02/20/2008 | EP1012324B1 Promiscuous g-protein compositions and their use |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0985039B1 Artificial antibody polypeptides |
| 02/20/2008 | EP0975745B1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
| 02/20/2008 | EP0970966B1 Fungal antigens and process for producing the same |
| 02/20/2008 | EP0907746B1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/20/2008 | EP0768890B1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 02/20/2008 | EP0731806B2 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128593A Method for reversing multiple resistance in animal cells |